References
Scopinaro F, Schillaci O, Scarpini M et al. Technetium-99m sestamibi: an indicator of breast cancer invasiveness.Eur J Nucl Med 1994; 21: 984–987.
Spiessl B, Beahrs OH, Hermanek P, et al.UICC TNM atlas: illustrated guide to TNMITpNM classification of malignant tumours, 3rd edn, 2nd revision. Springer, Berlin Heidelberg New York: 1992: 185–196.
Butcher HR. Radical mastectomy for mammary carcinoma.Ann Surg 1969; 170: 833–834.
Haagensen CD.Diseases of the breast, 3rd edn. Philadelphia: W.B. Saunders, 1986.
Schottenfeld D, Nash AG, Robbins GF, et al. Ten-years' results of the treatment of primary operable breast carcinoma.Cancer 1976; 38: 1001–1017.
Bucalossi P, Veronesi V, Zingo L, et al. Enlarged mastectomy for breast cancer; review of 1,213 cases.Am JRoentgenol Radium Ther Nucl Med 1971; 111: 119–122.
Scopinaro E, Schillaci O, Di Macio L, et al.99mTc sestamibi scan in breast cancer [abstract].Eur J Nucl Med 1993; 20: 979
Khalkhali I, Mena I, Jouanne E, et al. Prone scintimammography in patients with supsicion of carcinoma of the breast.J Am Coll Surg 1994; 178: 491–497.
Schweil AM, McKillop JH, Ziada G, et al. The optimum time for tumor imaging with thallium 201.Eur J Nucl Med 1988; 13: 527–529.
Kao CH, Yang MD, Wang SJ et al. The Tc-99m MIBI scintigraphy in the evaluation of mass abnormalities of the breast [abstract].Eur J Nucl Med 1993; 20: 979.
Morrow M, Foster RS. Staging of breast cancer; a new rationale for internal mammary node biopsy.Arch Surg 1983; 116: 748–751.
Livingstone SF, Arlen M. The extended pleural radical mastectomy: its role in the treatment of the carcinoma of the breast.Ann Surg 1974; 179: 260–267.
Fisher B, Bauer M, Wieckerham L, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with breast cancer: an NSABP update.Cancer 1983; 52: 1551–1557.
Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling.Cancer 1993; 72: 3248–3252.
Waxman A, Nagaraj N, Ashok G, et al. Sensitivity and specificity of Tc99m MIBI in the evaluation of primary carcinoma of the breast: comparison of palpable and non-palpable lesions with mammography [abstract].J Nucl Med 1994; 35 Suppl: 22P.
Khalkhali I, Cutrone J, Mena I, et al. Clinical and pathological follow-up of 100 patients with breast lesions studied with scintimammography [abstract].J Nucl Med 1994; 35 Suppl: 22P
Nagaraj N, Waxman A, Ashok G, et al. Comparison of SPECT and planar Tc99m sestamibi imaging in patients with carcinoma of the breast.J Nucl Med 1994; 35 Suppl: 229P.
Stowasser G, Pernegger C, Brinninger G, et al. Evaluation of Tc99m sestamibi in patients with suspected breast cancer in comparison with TI201.J Nucl Med 1994; 35 Suppl: 231P.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bourgeois, P. The use of technetium-99m sestamibi to indicate breast cancer invasiveness. Eur J Nucl Med 22, 581–582 (1995). https://doi.org/10.1007/BF00817286
Issue Date:
DOI: https://doi.org/10.1007/BF00817286